Alnylam Competitors and Similar CompaniesClear all

Sorrento Therapeutics's competitors and similar companies include Regulus Therapeutics and Ionis Pharmaceuticals.
Sorrento Therapeutics
Sorrento Therapeutics
Sorrento Therapeutics is focused on the development of proprietary drug therapeutics for addressing unmet medical needs.
Regulus Therapeutics
Regulus Therapeutics
Regulus Therapeutics is a biopharmaceutical company involved in the R&D of high-impact medicines based on microRNAs.
Ionis Pharmaceuticals
Ionis Pharmaceuticals
Ionis Pharmaceuticals (formerly known as Isis Pharmaceuticals) is a company that discovers and develops RNA-targeted therapeutics.
Founding Date
Founding Date
2006
Founding Date
2007
Founding Date
1989
Type
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
San Diego, US HQ
San Diego, US
Locations
San Diego, US HQ
Locations
Carlsbad, US HQ
Employees
Employees
31019% decrease
Employees
2462% decrease
Employees
92716% increase
Valuation ($)
Valuation ($)
1.5 m
Valuation ($)
105.4 m
Valuation ($)
6.3 b

Financial

Revenue (est.)
Revenue (est.)
$62.8m (FY, 2022)
Revenue (est.)
N/A
Revenue (est.)
$787.6m (FY, 2023)
Net income
Net income
($577.8m) (FY, 2022)
Net income
($30m) (FY, 2023)
Net income
($366.3m) (FY, 2023)

Funding

Total funding raised
Total funding raised
$ 42.6m
Total funding raised
$ 10m
Total funding raised
N/A
For sources of this data, please see the company profile

View Company Profiles

Regulus Therapeutics
HQ
San Diego, US
Employees
24

Regulus Therapeutics is a biopharmaceutical company involved in the R&D of high-impact medicines based on microRNAs.

View company
Ionis Pharmaceuticals
HQ
Carlsbad, US
Employees
927↑ 16% increase

Ionis Pharmaceuticals (formerly known as Isis Pharmaceuticals) is a company that discovers and develops RNA-targeted therapeutics.

View company